As the world of AI continues to grow, we will dive into a couple of programs that have sprouted in the Technology Transfer space to understand how AI can be used to help the process of university commercialization functions. Marc Sedam of NYU and James Zanewicz of Tulane University will join us to discuss how…
Recently, several universities and research institutions have set up internally driven and funded therapeutics development programs providing faculty the opportunity to push high impact translational research projects further than has been typically seen within an academic setting. These programs can oversee all stages of therapeutic discovery and development, from lab-based discovery to clinical trials. Why did these institutions decide to start these programs? How are these programs administered? What multi-disciplinary talent is needed and where did each institution find it? And perhaps most importantly, how much do these programs cost and who pays the bill?